Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How I treat autoimmune hemolytic anemia
Ronald S. Go, Jeffrey L. Winters, Neil E. Kay
Blood (2017) Vol. 129, Iss. 22, pp. 2971-2979
Open Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 17, pp. 1714-1768
Open Access | Times Cited: 3153
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Bryan J. Schneider, Jarushka Naidoo, Bianca Santomasso, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 36, pp. 4073-4126
Open Access | Times Cited: 577
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
Sara Barmettler, Mei‐Sing Ong, Jocelyn R. Farmer, et al.
JAMA Network Open (2018) Vol. 1, Iss. 7, pp. e184169-e184169
Open Access | Times Cited: 274
Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
Jean‐Marie Michot, Julien Lazarovici, Ashley Tieu, et al.
European Journal of Cancer (2019) Vol. 122, pp. 72-90
Closed Access | Times Cited: 137
Warm Autoimmune Hemolytic Anemia
Robert A. Brodsky
New England Journal of Medicine (2019) Vol. 381, Iss. 7, pp. 647-654
Closed Access | Times Cited: 115
Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4
Adriana A. de Jesus, Anja Brehm, Rachel VanTries, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 143, Iss. 5, pp. 1939-1943.e8
Open Access | Times Cited: 99
How I treat warm autoimmune hemolytic anemia
Wilma Barcellini, Bruno Fattizzo
Blood (2021) Vol. 137, Iss. 10, pp. 1283-1294
Open Access | Times Cited: 92
Anemia in the pediatric patient
Patrick G. Gallagher
Blood (2022) Vol. 140, Iss. 6, pp. 571-593
Open Access | Times Cited: 56
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors
Rebecca Karp Leaf, Christopher Ferreri, Deepa Rangachari, et al.
American Journal of Hematology (2019) Vol. 94, Iss. 5, pp. 563-574
Open Access | Times Cited: 61
COVID‐19 associated with severe autoimmune hemolytic anemia
Jeremy W. Jacobs, Quentin Eichbaum
Transfusion (2020) Vol. 61, Iss. 2, pp. 635-640
Open Access | Times Cited: 56
ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies
Filippo Consonni, Eleonora Gambineri, Claudio Favre
Annals of Hematology (2022) Vol. 101, Iss. 3, pp. 469-484
Open Access | Times Cited: 32
A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus
Juan Camilo Santacruz, Marta Juliana Mantilla, I. Rueda, et al.
Cureus (2022)
Open Access | Times Cited: 31
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers
Wilma Barcellini, Anna Zaninoni, Bruno Fattizzo, et al.
American Journal of Hematology (2018) Vol. 93, Iss. 9
Open Access | Times Cited: 59
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody
Ying‐Jun Chang, Lan‐Ping Xu, Yu Wang, et al.
Bone Marrow Transplantation (2020) Vol. 55, Iss. 7, pp. 1326-1336
Closed Access | Times Cited: 46
Current and emerging treatment options for autoimmune hemolytic anemia
Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni
Expert Review of Clinical Immunology (2018) Vol. 14, Iss. 10, pp. 857-872
Closed Access | Times Cited: 46
Hematological Manifestations among Patients with Rheumatic Diseases
Alina Klein, Yair Molad
Acta Haematologica (2020) Vol. 144, Iss. 4, pp. 403-412
Open Access | Times Cited: 38
Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study
Ebe Schiavo, Beatrice Martini, Enrico Attardi, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 22
Deciphering the role of molecular mimicry in the etiopathogenesis of Autoimmune Hemolytic Anemia using an immunoinformatics approach.
Pratyusha Patidar, Arihant Jain, Tulika Prakash
ImmunoInformatics (2025), pp. 100047-100047
Open Access
33-Year-Old Man With Fatigue
Jordan Nunnelee, Mackenzie Maberry, Ronald S. Go
Mayo Clinic Proceedings (2025)
Closed Access
Diagnostic challenges in DAT-negative autoimmune haemolytic anaemia
Laura McDuff, M. Lombard, Tony Calogero, et al.
BMJ Case Reports (2025) Vol. 18, Iss. 3, pp. e264551-e264551
Closed Access
Severe Malaria Infection Concurrent With Autoimmune Hemolytic Anemia and Acute Cytomegalovirus Infection: A Case Report
S Alsibai, Mohamad K Mohamad, Yousef S Alabrach, et al.
Cureus (2025)
Open Access
Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases
Luis Malpica, Stephan Moll
Hematology (2020) Vol. 2020, Iss. 1, pp. 319-327
Open Access | Times Cited: 30
Guideline for the treatment of chronic lymphocytic leukaemia
Anna Schuh, Nilima Parry‐Jones, Niamh Appleby, et al.
British Journal of Haematology (2018) Vol. 182, Iss. 3, pp. 344-359
Open Access | Times Cited: 29
Management of the Top 10 Most Common Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy
Bryan J. Schneider, Christina Lacchetti, Kathryn Bollin
JCO Oncology Practice (2022) Vol. 18, Iss. 6, pp. 431-444
Open Access | Times Cited: 15
Guía de práctica clínica para el manejo del lupus eritematoso sistémico propuesta por el Colegio Mexicano de Reumatología
D. X. Xibille Friedmann, Marcela Pérez‐Rodríguez, Sandra Carrillo-Vázquez, et al.
Reumatología Clínica (2018) Vol. 15, Iss. 1, pp. 3-20
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top